Roller P P, Wu L, Zhang Z Y, Burke T R
Laboratory of Medicinal Chemistry, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Bioorg Med Chem Lett. 1998 Aug 18;8(16):2149-50. doi: 10.1016/s0960-894x(98)00376-x.
To enhance PTP binding interactions, both inside and outside the pTyr binding pocket, a thioether-cyclized peptide has been designed based on the EGF receptor autophosphorylation sequence (EGFR988-993) "Asp-Ala-Asp-Glu-pTyr-Leu", in which the pTyr resiude has been replaced by the nonphosphorus-containing pTyr mimetic fluoro-O-malonyltyrosine (FOMT, 2). The resulting peptide 4 exhibits a Ki value of 170 nM, making it one of the most potent inhibitors of PTP1B yet reported.
为增强PTP结合相互作用,在磷酸化酪氨酸(pTyr)结合口袋内外,基于表皮生长因子受体(EGF受体)自身磷酸化序列(EGFR988 - 993)“Asp - Ala - Asp - Glu - pTyr - Leu”设计了一种硫醚环化肽,其中pTyr残基已被不含磷的pTyr模拟物氟代O - 丙二酰酪氨酸(FOMT,2)取代。所得肽4的抑制常数(Ki)值为170 nM,使其成为迄今报道的最有效的蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂之一。